Clinical Trial

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

Study acronym: EMBOLD
Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-04-17; most recent amendment 2026-01-27.
Status change: Recruiting → Active, Not Recruiting 2026-01-27
Trial Details
NCT Number NCT05818553
Lead Sponsor Praxis Precision Medicines
Conditions SCN2A Encephalopathy, SCN8A Encephalopathy
Enrollment 77 participants
Start Date 2023-08-02
Primary Completion 2025-11-12 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-29